RecruitingNot ApplicableNCT06044168

Feasibility Nutritional Supplements for Muscle Growth in CP

Feasibility Study: Nutritional Supplements to Support Muscle Growth in Children With Cerebral Palsy


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

5 participants

Start Date

Jul 31, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to investigate the feasibility of a 10-week plan with a nutritional supplement (leucine) and to perform pilot analyses on the effect of leucine on macroscopic muscle morphology in children with cerebral palsy.


Eligibility

Min Age: 4 YearsMax Age: 10 Years

Inclusion Criteria4

  • Spastic Cerebral Palsy (diagnosed by a neuro-pediatrician from the CP Reference Centre of the University Hospital Leuven)
  • Uni- of bilateral involvement
  • Level II or III on the Gross Motor Function Classification System (GMFCS)
  • Muscle volume for the medial gastrocnemius (target muscle) of at least 20% compared to the expected muscle volume in age-matched typically developing children

Exclusion Criteria6

  • Presence of dyskinesia or ataxia
  • Severe co-morbidities
  • Botulinum toxin treatment ten months prior to assessment
  • Previous orthopedic or neurosurgery
  • Severe ankle deformities preventing fitting in test positions
  • Ankle range of motion (ROM) \<30% of normal values

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTDietary Supplement: Leucine

150mg/kg body mass/day


Locations(1)

UZ Leuven

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06044168


Related Trials